Search for Clinical Trial Results
Indolent B Cell Lymphoma - 25 Studies Found
Status | Study |
Completed |
Study Name: Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma Condition:
|
Withdrawn |
Study Name: Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma Condition: Lymphoma Date: 1999-12-10 Interventions:
|
Withdrawn |
Study Name: Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) Condition:
|
Not yet recruiting |
Study Name: Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL Condition:
|